5 Best Dividend Stocks to Buy According to Irving Kahn’s Hedge Fund

3. GlaxoSmithKline plc (NYSE: GSK)

Kahn Brothers’ Stake Value: $45,175,000
Percentage of Kahn Brothers’ 13F Portfolio: 6.99%
Dividend Yield: 5.51%
Number of Hedge Fund Holders: 25

GlaxoSmithKline plc (NYSE: GSK) is a multinational pharmaceutical company. The company was founded in 1715, and it stands third on the list of 10 best dividend stocks to buy according to Irving Kahn’s fund. GlaxoSmithKline currently has a $100.04 billion market capitalization. 

On July 6, Morgan Stanley analyst Mark Purcell raised the firm’s price target on GlaxoSmithKline plc (NYSE: GSK) to 1,590 GBp from 1,550 GBp and kept an “Equal Weight” rating on the shares.

Irving Kahn’s Kahn Brothers currently holds 1.27 million shares of GlaxoSmithKline plc (NYSE: GSK) that amounts to $45.18 million. GlaxoSmithKline occupies 6.99% of Kahn Brothers’ total portfolio. Out of the hedge funds being tracked by Insider Monkey, Fisher Asset Management is a leading shareholder in GlaxoSmithKline plc (NYSE: GSK) with 17.02 million shares worth more than $607 million.